Sort by
AUM ₹4915 Cr •
Expense 1.11%
AUM ₹3313 Cr •
Expense 0.97%
AUM ₹3198 Cr •
Expense 0.63%
AUM ₹2667 Cr •
Expense 0.52%
AUM ₹8081 Cr •
Expense 0.91%
AUM ₹1042 Cr •
Expense 1.23%
AUM ₹1184 Cr •
Expense 0.74%
AUM ₹815 Cr •
Expense 1.1%
AUM ₹83 Cr •
Expense 1.22%
AUM ₹214 Cr •
Expense 0.47%
AUM ₹370 Cr •
Expense 0.78%
AUM ₹1634 Cr •
Expense 0.94%
AUM ₹412 Cr •
Expense 0.78%
AUM ₹271 Cr •
Expense 0.72%
AUM ₹96 Cr •
Expense 0.66%
AUM ₹307 Cr •
Expense 0.61%
In the past six months, the HDFC Pharma and Healthcare Fund Direct Growth has emerged as the leader in AUM growth, witnessing an impressive addition of ₹299.1 crore. This positions it as one of the top-performing Sector Healthcare mutual funds in terms of investor interest and fund growth.
Over the last six months, 10 Sector Healthcare Mutual Funds have added Sai Life Sciences Ltd to their portfolio. This move highlights the stock’s growing appeal in the segment as a promising investment.
In contrast, Emcure Pharmaceuticals Ltd has been exited by 5 of 16 Sector Healthcare Mutual Funds in the last six months. This shift underscores a cautious approach by fund managers toward the stock, reflecting changing market dynamics.
Over the last 6 months, Sector Healthcare category has seen increased allocation towards Industrial, Consumer Defensive, Basic Materials sectors and allocation in Tech, Energy, Financial Services sectors has decreased
Calculate your Mutual Funds Lumpsum & SIP Returns for free with INDmoney Calculators